(1S,17R)-14-(cyclopropylmethyl)-1,5,17-trimethyl-6,8,14-triazatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4,6,8,10-pentaene

C21H27N3 — CID 59334295

IUPAC(1S,17R)-14-(cyclopropylmethyl)-1,5,17-trimethyl-6,8,14-triazatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4,6,8,10-pentaene
SMILESCc1ncnc2cc3c(cc12)[C@@]1(C)CCN(CC2CC2)C(C3)[C@@H]1C
InChIInChI=1S/C21H27N3/c1-13-20-9-16-8-19-17(14(2)22-12-23-19)10-18(16)21(13,3)6-7-24(20)11-15-4-5-15/h8,10,12-13,15,20H,4-7,9,11H2,1-3H3/t13-,20?,21-/m0/s1
InChIKeyWWMZTRJECQTMBF-CMVRGNNWSA-N
MW321.47 g/mol
LogP3.87
Rot. Bonds2

About (1S,17R)-14-(cyclopropylmethyl)-1,5,17-trimethyl-6,8,14-triazatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4,6,8,10-pentaene

(1S,17R)-14-(cyclopropylmethyl)-1,5,17-trimethyl-6,8,14-triazatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4,6,8,10-pentaene (PubChem CID 59334295) has the molecular formula C21H27N3 and a molecular weight of 321.47 g/mol. Its IUPAC name is (1S,17R)-14-(cyclopropylmethyl)-1,5,17-trimethyl-6,8,14-triazatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4,6,8,10-pentaene.

Molecular Properties

Compound Name(1S,17R)-14-(cyclopropylmethyl)-1,5,17-trimethyl-6,8,14-triazatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4,6,8,10-pentaene
PubChem CID59334295
Molecular FormulaC21H27N3
Molecular Weight321.47 g/mol
Exact Mass321.22
IUPAC Name(1S,17R)-14-(cyclopropylmethyl)-1,5,17-trimethyl-6,8,14-triazatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4,6,8,10-pentaene
SMILESCc1ncnc2cc3c(cc12)[C@@]1(C)CCN(CC2CC2)C(C3)[C@@H]1C
InChIInChI=1S/C21H27N3/c1-13-20-9-16-8-19-17(14(2)22-12-23-19)10-18(16)21(13,3)6-7-24(20)11-15-4-5-15/h8,10,12-13,15,20H,4-7,9,11H2,1-3H3/t13-,20?,21-/m0/s1
InChIKeyWWMZTRJECQTMBF-CMVRGNNWSA-N
XLogP3.87
TPSA29.02 Ų
H-Bond Donors
H-Bond Acceptors3
Rotatable Bonds2
Heavy Atoms24
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500321.47
LogP ≤ 53.87
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 103

Analyze (1S,17R)-14-(cyclopropylmethyl)-1,5,17-trimethyl-6,8,14-triazatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4,6,8,10-pentaene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1S,17R)-14-(cyclopropylmethyl)-1,5,17-trimethyl-6,8,14-triazatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4,6,8,10-pentaene?
The IUPAC name of (1S,17R)-14-(cyclopropylmethyl)-1,5,17-trimethyl-6,8,14-triazatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4,6,8,10-pentaene (CID 59334295) is (1S,17R)-14-(cyclopropylmethyl)-1,5,17-trimethyl-6,8,14-triazatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4,6,8,10-pentaene.
What is the SMILES notation for (1S,17R)-14-(cyclopropylmethyl)-1,5,17-trimethyl-6,8,14-triazatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4,6,8,10-pentaene?
The canonical SMILES for (1S,17R)-14-(cyclopropylmethyl)-1,5,17-trimethyl-6,8,14-triazatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4,6,8,10-pentaene is Cc1ncnc2cc3c(cc12)[C@@]1(C)CCN(CC2CC2)C(C3)[C@@H]1C.
What is the InChIKey of (1S,17R)-14-(cyclopropylmethyl)-1,5,17-trimethyl-6,8,14-triazatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4,6,8,10-pentaene?
The InChIKey is WWMZTRJECQTMBF-CMVRGNNWSA-N. The full InChI is InChI=1S/C21H27N3/c1-13-20-9-16-8-19-17(14(2)22-12-23-19)10-18(16)21(13,3)6-7-24(20)11-15-4-5-15/h8,10,12-13,15,20H,4-7,9,11H2,1-3H3/t13-,20?,21-/m0/s1.
What are the key properties of (1S,17R)-14-(cyclopropylmethyl)-1,5,17-trimethyl-6,8,14-triazatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4,6,8,10-pentaene?
(1S,17R)-14-(cyclopropylmethyl)-1,5,17-trimethyl-6,8,14-triazatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4,6,8,10-pentaene has a molecular weight of 321.47 g/mol, XLogP of 3.87, 2 rotatable bonds, 0 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for (1S,17R)-14-(cyclopropylmethyl)-1,5,17-trimethyl-6,8,14-triazatetracyclo[11.3.1.02,11.04,9]heptadeca-2,4,6,8,10-pentaene is sourced from PubChem (CID 59334295), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).